PPCS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.412000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.339200E-01
Normal-vs-Stage2
6.109000E-01
Normal-vs-Stage3
8.107700E-02
Normal-vs-Stage4
8.418400E-01
Stage1-vs-Stage2
9.351200E-01
Stage1-vs-Stage3
3.870800E-01
Stage1-vs-Stage4
5.147400E-01
Stage2-vs-Stage3
2.488600E-01
Stage2-vs-Stage4
4.079600E-01
Stage3-vs-Stage4
1.238610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.438200E-01
Normal-vs-AfricanAmerican
4.625800E-01
Normal-vs-Asian
6.302800E-01
Caucasian-vs-AfricanAmerican
9.783000E-01
Caucasian-vs-Asian
7.956600E-01
AfricanAmerican-vs-Asian
8.358400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.001000E-01
Normal-vs-Female
6.066400E-01
Male-vs-Female
2.582400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.825780E-01
Normal-vs-Age(41-60Yrs)
4.916800E-01
Normal-vs-Age(61-80Yrs)
5.714800E-01
Normal-vs-Age(81-100Yrs)
5.047400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.591570E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.830400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.376400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.671800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.407600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.928200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.202600E-01
Normal-vs-Daily Drinker
4.997400E-01
Normal-vs-Weekly Drinker
6.951600E-02
Normal-vs-Occasional Drinker
7.362400E-01
Normal-vs-Social Drinker
1.538440E-01
Non Drinker-vs-Daily Drinker
9.170800E-01
Non Drinker-vs-Weekly Drinker
1.324380E-01
Non Drinker-vs-Occasional Drinker
2.452800E-01
Non Drinker-vs-Social Drinker
7.190200E-01
Daily Drinker-vs-Weekly Drinker
1.530600E-01
Daily Drinker-vs-Occasional Drinker
3.478400E-01
Daily Drinker-vs-Social Drinker
6.446600E-01
Weekly Drinker-vs-Occasional Drinker
7.816100E-03
Weekly Drinker-vs-Social Drinker
1.823410E-01
Occasional Drinker-vs-Social Drinker
9.545600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.884600E-01
Normal-vs-Grade 2
5.399500E-03
Normal-vs-Grade 3
2.183700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.088800E-01
Grade 1-vs-Grade 3
8.772200E-01
Grade 1-vs-Grade 4
2.884600E-01
Grade 2-vs-Grade 3
6.078200E-01
Grade 2-vs-Grade 4
5.399500E-03
Grade 3-vs-Grade 4
2.183700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.797190E-01
Normal-vs-NonDiabetic
3.682800E-01
Diabetic-vs-NonDiabetic
1.568230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.499600E-01
Normal-vs-NoPancreatitis
3.307000E-01
Pancreatitis-vs-NoPancreatitis
5.272400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.534800E-01
Normal-vs-N1
6.610000E-01
N0-vs-N1
1.713800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.553400E-01
Normal-vs-TP53-NonMutant
7.286800E-01
TP53-Mutant-vs-TP53-NonMutant
1.285190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
